Navigation Links
LOTUS™ Electronic Oxygen Conserver (without alarm)

ProductsLOTUS™ Electronic Oxygen Conserver (without alarm)
Company CHAD Therapeutics, Inc.
Item LOTUS™ Electronic Oxygen Conserver (without alarm)
Features 
  • Provides every-breath delivery with a built-in regulator.
  • Offers a 5:1 increase in usage time! This means that an oxygen cylinder used in conjunction with a LOTUS conserver will last five times longer than a cylinder without a conserving device.
  • Offers 1-6 lpm flow equivalency settings, including 1.5 and 2.5.
  • Delivers fixed pulses of oxygen within the first 200 milliseconds of inspiration.
  • Sleek, lightweight design - only 14.5 oz.
  • Simple patient operation. One control knob does it all!
  • Equipped with an audible and visual low battery alarm.
  • Extended battery life - up to four months at eight hours per day use.
  • Uses two AA-size alkaline batteries.
  • Optional rechargeable battery pack and charger allows the patient to recharge the battery even while in use.
  • Reliability backed by a 2-year warranty.
  • Description Redesigning the World's Oxygen Therapy One Device at a Time.

    Everything you like about our OXYMATIC 400 Series conservers, only better!
    Info CHAD Therapeutics, Inc.
    Customer Service: (800) 423-8870
    Web site: http://www.chadtherapeutics.com

    Related medicine products :

    1. LOTUS™ Electronic Oxygen Conserver (with alarm)
    2. MaximEyes Practice Management and Electronic Medical Records Software Solutions
    3. PRAXIS® Electronic Medical Records v. 2.19
    4. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
    5. ExamWRITER Electronic Medical Records
    6. NextGen Electronic Medical Records module
    7. PrimeSuite Integrated Practice Management, Electronic Medical Record (EMR) and Managed Care solutions
    8. Cardiology Software for Electronic Medical Records
    9. HealthMatics EMR Electronic Medical Record
    10. Littmann Electronic Stethoscope Model 2000
    11. 3M Littmann Electronic Stethoscope Model 4100WS with Ambient Noise Reduction
    ...le pre-fabricated orthosis is designed for the man...yseal fractures. The lightweight anatomical design...e compression for optimal control of humeral segme...e shoulder and elbow joints. It is formed of a spe...
    The FUNCTIONAL ARM BRACE (FAB) was designed to allow immobilization in multiple positions to make it useful as a functional brace in early rehabilitation., ,Far more than an "Elbow ROM Brace" - the
    ...Flexion MPO® by RCAI provides adjustable stati...scular involvement conditions such as diminished f...hip rotation. Medial/lateral straps attached to th...e controlled, as needed, in the desired dorsi-flex...
    The design of the Hi-Top ankle strap allow the foot to be held back in the heel cup of the shoe counter. The front is cut back which relieves pressure and compression on the toes. Features breathable
    Medicine Products:
    (Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
    (Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
    (Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
    (Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
    Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
    ...ay the a new vaccine effective against the 1918 de...u has been developed//. This is likely to lead to ...which may may the jump into humans and turn just a...anish flu,thought to have been triggered off by un...
    ...sue of the journal Radiology revealed that accurat...a three-dimensional computed tomography (CT) colon...want to be screened by this method when it is cove...e experience with virtual colonoscopy screening co...
    ...ociation has published a report on Tuesday about a...ly prescribed and OTC crugs have caused// many a p...lised. The sample data for the study consisted of...ing 2004 and 2005, and it was determined from this...
    ...to get overweight youngsters lose weight by concen...ff and are likely to make them// gorge even more, ...t they are no more motivated to change their eatin... happy with their appearance. Rather the researc...
    Other Medicine News:Health News:Virtual Colonoscopy in Colorectal Cancer Prevention and Screening 2Health News:Virtual Colonoscopy in Colorectal Cancer Prevention and Screening 3Health News:Obese Kids Unmotivated byWeight Loss campaigns 2
    (Date:10/10/2008)... Calif., Oct. 10 /- TriReme Medical I...zed to affix the CE (Conformite,Europeenne) markin...nary,Stent System, a unique main vessel stent syst...bifurcations., Representing the next generation i... potential use in a quarter of the 2.2 million,ang...
    (Date:10/9/2008)...nslational Science Institute, Navigenics, Affymetr...dy, SAN DIEGO, Oct. 9 /- A consortiu...have joined forces in a first-of-its-kind,research... genetic testing,on people who choose to receive s...r developing certain diseases., Sponsored by Scri...
    (Date:10/8/2008)...rt Institute Pioneers Research That May Offer New ...- Nationally, over 3,000 people are,w... life. Sadly, only half,of those will receive a tr...t Institute (AHI) is paving the way for how to tre...iew the Multimedia News Release, go to:, http://ww...
    (Date:10/8/2008)...e, Oct. 8 /- Vical Incorporated (Nasd...data and new nonclinical data,demonstrating that t...applicable in DNA- and protein-based infectious di...Alain P. Rolland, Pharm.D., Ph.D., Vical,s,Senior ...t the data today,Wednesday, October 8, at the Wor...
    Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference 4529 1Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference 4529 2Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Di 1740 1Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Di 1740 2Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Di 1740 3Irradiation Almost Erases Risk of Food Poisoning 16539 1Irradiation Almost Erases Risk of Food Poisoning 16539 2Irradiation Almost Erases Risk of Food Poisoning 16539 3Irradiation Almost Erases Risk of Food Poisoning 16539 4Penn researchers discover modus operandi of heart muscle protein 16537 1Penn researchers discover modus operandi of heart muscle protein 16537 2
    ...nd quarter BLA filing for C1-inhibitor,replacement...stCall/ -- Lev,Pharmaceuticals, Inc. (Lev) today a...ase III trial of C1-esterase inhibitor (C1-INH),fo...E). In the,acute study, which is part of the compa...ioedema Nanofiltration Generation,evaluating Effic...
    ... 2007-- The cause of one notorious,childhood disea...,threat of another childhood disease, neuroblastom...rchers from Stony Brook University,report that an ...s,is effective in obliterating neuroblastoma tumor...vaccinated against the virus. , By its nature, pol...
    Other Medicine Technology:Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4